224 related articles for article (PubMed ID: 22393204)
1. Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression.
Agrawal A; Nelson EC; Littlefield AK; Bucholz KK; Degenhardt L; Henders AK; Madden PA; Martin NG; Montgomery GW; Pergadia ML; Sher KJ; Heath AC; Lynskey MT
Arch Gen Psychiatry; 2012 Jul; 69(7):732-40. PubMed ID: 22393204
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid Receptor 1 rs1049353 Variant, Childhood Abuse, and the Heterogeneity of PTSD Symptoms: Results From the National Health and Resilience in Veterans Study.
Korem N; Duek O; Xu K; Harpaz-Rotem I; Pietrzak RH
Chronic Stress (Thousand Oaks); 2021; 5():24705470211011075. PubMed ID: 33997583
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of major depression by childhood abuse is not modified by CNR1 genotype.
Pearson JF; Fergusson DM; Horwood LJ; Miller AL; Sullivan PF; Youfang LE; Kennedy MA
Am J Med Genet B Neuropsychiatr Genet; 2013 Mar; 162B(2):224-6. PubMed ID: 23255320
[No Abstract] [Full Text] [Related]
4. The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms.
Mota N; Sumner JA; Lowe SR; Neumeister A; Uddin M; Aiello AE; Wildman DE; Galea S; Koenen KC; Pietrzak RH
J Clin Psychiatry; 2015 Dec; 76(12):e1622-3. PubMed ID: 26717543
[No Abstract] [Full Text] [Related]
5. [Association study of CNR1, GAD1 and BDNF polymorphisms with male heroin dependence in the Dai population in Yunnan].
Yang Y; Chen Y; Wu J; Xing Y; Zeng F; Huang Y; Cheng BW
Yi Chuan; 2014 Sep; 36(9):888-96. PubMed ID: 25252306
[TBL] [Abstract][Full Text] [Related]
6. Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.
Carey CE; Agrawal A; Zhang B; Conley ED; Degenhardt L; Heath AC; Li D; Lynskey MT; Martin NG; Montgomery GW; Wang T; Bierut LJ; Hariri AR; Nelson EC; Bogdan R
J Abnorm Psychol; 2015 Nov; 124(4):860-77. PubMed ID: 26595473
[TBL] [Abstract][Full Text] [Related]
7. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
[TBL] [Abstract][Full Text] [Related]
8.
Palmer RHC; McGeary JE; Knopik VS; Bidwell LC; Metrik JM
Am J Drug Alcohol Abuse; 2019; 45(5):514-526. PubMed ID: 31184938
[No Abstract] [Full Text] [Related]
9. No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents.
Müller TD; Reichwald K; Wermter AK; Brönner G; Nguyen TT; Friedel S; Koberwitz K; Engeli S; Lichtner P; Meitinger T; Schäfer H; Hebebrand J; Hinney A
Mol Genet Metab; 2007 Apr; 90(4):429-34. PubMed ID: 17292652
[TBL] [Abstract][Full Text] [Related]
10. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor 1 gene is associated with alcohol dependence.
Marcos M; Pastor I; de la Calle C; Barrio-Real L; Laso FJ; González-Sarmiento R
Alcohol Clin Exp Res; 2012 Feb; 36(2):267-71. PubMed ID: 22085192
[TBL] [Abstract][Full Text] [Related]
12. The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults.
Hartman CA; Hopfer CJ; Haberstick B; Rhee SH; Crowley TJ; Corley RP; Hewitt JK; Ehringer MA
Drug Alcohol Depend; 2009 Sep; 104(1-2):11-6. PubMed ID: 19443135
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between rs1049353 polymorphism of the CNR1 gene and suicide attempt frequency in Polish population.
Wierzbiński P; Henzler M; Hubska J
Pol Merkur Lekarski; 2022 Dec; 50(300):356-359. PubMed ID: 36645680
[TBL] [Abstract][Full Text] [Related]
14. Childhood Maltreatment and Anhedonic Symptoms: Test of a Dual-risk Model in Emerging Adults.
Cohen JR; McNeil S; Menon SV
J Interpers Violence; 2022 May; 37(9-10):NP7447-NP7469. PubMed ID: 33118458
[TBL] [Abstract][Full Text] [Related]
15. Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females.
de Luis DA; Izaola O; Aller R; Lopez JJ; Torres B; Diaz G; Gomez E; Romero E
J Hum Nutr Diet; 2016 Feb; 29(1):118-23. PubMed ID: 25664923
[TBL] [Abstract][Full Text] [Related]
16. Stress-related anhedonia is associated with ventral striatum reactivity to reward and transdiagnostic psychiatric symptomatology.
Corral-Frías NS; Nikolova YS; Michalski LJ; Baranger DA; Hariri AR; Bogdan R
Psychol Med; 2015; 45(12):2605-17. PubMed ID: 25853627
[TBL] [Abstract][Full Text] [Related]
17. The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia.
Dinu IR; Popa SG; Moţa M; Moţa E; Stănciulescu C; Ioana M; Cruce M
Rom J Morphol Embryol; 2011; 52(3):791-5. PubMed ID: 21892520
[TBL] [Abstract][Full Text] [Related]
18. Gene-Environment Interaction in Youth Depression: Replication of the 5-HTTLPR Moderation in a Diverse Setting.
Rocha TB; Hutz MH; Salatino-Oliveira A; Genro JP; Polanczyk GV; Sato JR; Wehrmeister FC; Barros FC; Menezes AM; Rohde LA; Anselmi L; Kieling C
Am J Psychiatry; 2015 Oct; 172(10):978-85. PubMed ID: 26315979
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
Domschke K; Dannlowski U; Ohrmann P; Lawford B; Bauer J; Kugel H; Heindel W; Young R; Morris P; Arolt V; Deckert J; Suslow T; Baune BT
Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347
[TBL] [Abstract][Full Text] [Related]
20. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms.
Juhasz G; Chase D; Pegg E; Downey D; Toth ZG; Stones K; Platt H; Mekli K; Payton A; Elliott R; Anderson IM; Deakin JF
Neuropsychopharmacology; 2009 Jul; 34(8):2019-27. PubMed ID: 19242408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
